Skip to main content
SpringerLink
Log in

Extended course of prednisolone saves costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Webb NJA, et al. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation. BMJ 2019: l1800, No. 365, 23 May 2019. Available from: URL: https://doi.org/10.1136/bmj.l1800

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Extended course of prednisolone saves costs. PharmacoEcon Outcomes News 829, 10 (2019). https://doi.org/10.1007/s40274-019-5924-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5924-4

Search

Navigation